BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//IAS-USA//NONSGML PDA Calendar Version 1.0//EN
CALSCALE:GREGORIAN
BEGIN:VEVENT
UID:20564b4af34be38d562eb5c8e231ca17
ORGANIZER:registration@iasusa.org
DTSTAMP:20261027T104838Z
LOCATION:
SUMMARY:Optimizing the Evaluation and Management of Osteoporosis in the HIV-Infected Patient
DESCRIPTION:Overview\n\nAssessment of Needs\nThe IAS–USA offers this state-of-the-art activity on the evolving challenges of managing HIV disease as part of a nationwide continuing medical education (CME) effort for physicians.\n\nFractures will become increasingly common as the population living with HIV gets into their 5th and 6th decade and beyond and will contribute to both morbidity and mortality. There is good evidence that the prevalence of osteoporosis is higher in people with HIV compared to people without HIV of the same age.  The reasons for this are multiple\, including a high burden of traditional osteoporosis risk factors in those with HIV\, effects of certain antiretroviral therapies\, and effects of chronic HIV infection.  This webinar will focus on what providers and patients can do to prevent fractures from happening to preserve lifespans and health spans in patients aging with HIV.\nLearning Objectives\nOn the completion of the webinar\, participants will be able to:\n\n 	Describe the risk factors for bone loss in HIV-infected persons\n 	Manage antiretroviral therapy to minimize the impact on bone\n 	List treatments to improve bone health in HIV-infected persons\n 	Describe the risks and benefits of treatments\n\nRegistration\nWho Should Attend\nThis advanced webinar is designed for clinical decision makers who are actively involved in HIV care and research.\n\nThis activity is also relevant for registered nurses\, PharmDs\, and other health professionals.\n\nIndividual registration is required\, even if you are viewing as a group\, in order to receive CME credit or a certificate of participation.\n\nRegistration closes on Monday\, January 8\, 2018\, 4:00 PM (PT).\n\nCertificates will be available after the completion of the evaluation and claim form.\n\nFor more information or questions\, please contact the registration department at registration@iasusa.org or 415-544-9400.\nConflicts of Interest\nIn the interest of maintaining the independence of its CME activities\, and in accordance with the policies of the Accreditation Council for Continuing Medical Education (ACCME)\, the IAS–USA requires all persons with control of content (eg\, faculty\, IAS–USA Board members\, and program staff) to disclose any financial relationships that they or their spouses or partners have had with commercial companies within the past 12 months. Any real or apparent conflicts of interest of those parties are resolved prior to the CME activity being delivered. Individuals who refuse to disclose financial interests may not participate in an IAS–USA CME activity.\n\n\n\n\nContinuing Education Credits\n\nCME Credits\nThe International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.\n\nThe IAS–USA designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.\nNursing Credits\nEducational Review Systems is an approved approver of continuing nursing education by the Alabama State Nursing Association\, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.  Provider # 5-115. This program is approved for 1.25 hours of continuing nursing education.\n\nEducational Review Systems is also approved for nursing continuing education by the state of California\, the state of Florida and the District of Columbia.\nPharmacy Credits\nEducational Review Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program is approved for 1.25 hours (0.125 CEUs) of continuing pharmacy education credit. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit.\nUAN # 0761-9999-18-001-L01-P\n\n\n\n\nGrant Support\n\n\nThis activity is part of the IAS–USA national educational effort that is funded\, in part\, by charitable contributions from commercial companies. Per IAS–USA policy\, any effort that uses commercial grants must receive grants from several companies with competing products. Funds are pooled and distributed to activities at the sole discretion of the IAS–USA. Grantors have no input into any activity\, including its content\, development\, or selection of topics or speakers. Generous support for this activity has been received from the following contributors.\n\nPLATINUM SUPPORTERS\nGilead Sciences\, Inc\nViiV Healthcare\n\nSILVER SUPPORTER\nJanssen Therapeutics\nFrequently Asked Questions\nView our list of FAQs about attending a webinar.\n\nFurther Questions?\nPlease contact the registration department at registration@iasusa.org or 415-544-9400.
STATUS:CONFIRMED
CATEGORIES:Webinars
URL;VALUE=URI:https://www.iasusa.org/events/webinar-2018-brown/
DTSTART:20180109T180000Z
DTEND:20180109T191500Z
END:VEVENT
END:VCALENDAR